HIV Waiting Room: Well-informed, HIV treatment-experienced patient looking for ways to simplify his regimen

Released On
December 18, 2019

Expires On
March 31, 2021

Media Type

Completion Time
60 minutes

HIV Specialists


Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Global Education Group and Integritas Communications.


Supported by an educational grant from Gilead Sciences, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for infectious disease and HIV specialist physicians and other clinicians involved in the care of patients with HIV infection.

Statement of Need/Program Overview

Patients with HIV will frequently switch regimens due to virologic failure, comorbidities, or desire for simplification. A treatment-experienced patient has different needs than a patient initiating treatment, including antiretroviral (ART) history and existing comorbidities that may be exacerbated by their current ART. Currently, there are many options for switching ART regimens, both within and between classes. This case-based interactive activity focuses on a treatment-experienced, knowledgeable patient who has developed comorbidities due to his current ART regimen, creating a clinical scenario addressing reasons for switching treatment, within- and between-class options, 2-drug regimens, and factors to consider when selecting a new ART regimen.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Utilize HIV-switching strategies that offer simplified dosing and/or improved tolerability for long-term outcomes in patients stable on their current regimens


Carlos Del Rio, MD

Emory Vaccine Center
Professor and Chair
Hubert Department of Global Health, Rollins School of Public Health
Department of Medicine, Division of Infectious Diseases
Emory University School of Medicine
Emory Center for AIDS Research
Atlanta, Georgia

Richard A. Elion, MD, MA

Clinical Professor of Medicine
George Washington University, School of Medicine
Senior Policy Advisor, Trio Health
Director, HIV/HCV Clinical and Research Program
Washington Health Institute
Washington, District of Columbia

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Global requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Carlos Del Rio, MD

  • Consultant/Independent Contractor: Merck & Co., Inc. (Consultant/Scientific input)
  • Grant/Research Support: National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAIDS) – Grant to my institution (Emory Center for AIDS Research), National Institutes of Health (NIH)/BNIAID – Grant to my institution (Emory HIV Clinical Trials Unit)

Richard A. Elion, MD, MA

  • Consultant/Independent Contractor: Gilead Sciences, Inc
  • Grant/Research Support: Gilead Sciences, Inc., ViiV Healthcare Limited
  • Honoraria: Gilead Sciences, Inc., ViiV Healthcare Limited
  • Speaker’s Bureau: Gilead Sciences, Inc., ViiV Healthcare Limited
  • Other/Royalty (Describe): Works with Trio Health, Inc., who receives grants from Gilead Sciences, Inc., ViiV Healthcare Limited

The following planners and managers reported neither they nor their spouses/life partners have financial relationships or relationships to products or devices they with commercial interests related to the content of this CME activity:

Lindsay Borvansky; Andrea Funk; Liddy Knight; Ashley Cann; Gena Dolson, MS; Stacey JP Ulman, MHS; Jim Kappler, PhD

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation

In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 65% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 65%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.

There is no fee for this educational activity.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or